We are live on ! Find out more
FNA

First National Advisers Portfolio holdings

AUM $712M
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
10 Year Est. Return
AUM
$683M
AUM Growth
+$58.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.79%
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.54M
2
TMO icon
Thermo Fisher Scientific
TMO
+$1.95M
3
CMCSA icon
Comcast
CMCSA
+$1.76M
4
CDW icon
CDW
CDW
+$1.48M
5
MDT icon
Medtronic
MDT
+$1.35M

Sector Composition

Rank Sector Weight
1 Technology 26.89%
2 Financials 15.07%
3 Consumer Discretionary 8.56%
4 Healthcare 8.13%
5 Industrials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
76
Arista Networks
ANET
$227B
$2.76M 0.4%
+26,985
New +$2.33M
TKR icon
77
Timken Company
TKR
$9.56B
$2.68M 0.39%
36,968
-103
-0.3% -$7.01K
LW icon
78
Lamb Weston
LW
$7.22B
$2.58M 0.38%
49,756
+301
+0.6% +$16.1K
PWR icon
79
Quanta Services
PWR
$100B
$2.57M 0.38%
6,802
+217
+3% +$69.7K
TXRH icon
80
Texas Roadhouse
TXRH
$13.5B
$2.52M 0.37%
13,450
+387
+3% +$69.4K
TMUS icon
81
T-Mobile US
TMUS
$185B
$2.52M 0.37%
10,563
+502
+5% +$123K
PTC icon
82
PTC
PTC
$15.8B
$2.51M 0.37%
14,549
+593
+4% +$95.6K
FR icon
83
First Industrial Realty Trust
FR
$8.73B
$2.5M 0.37%
51,885
+687
+1% +$33.5K
PG icon
84
Procter & Gamble
PG
$336B
$2.48M 0.36%
15,588
+189
+1% +$30.8K
UFPT icon
85
UFP Technologies
UFPT
$1.97B
$2.47M 0.36%
10,103
+336
+3% +$75.6K
BCPC
86
Balchem Corp
BCPC
$5.38B
$2.46M 0.36%
15,443
+12,911
+510% +$2.09M
MDLZ icon
87
Mondelez International
MDLZ
$79.5B
$2.45M 0.36%
36,374
+524
+1% +$35K
NSSC icon
88
Napco Security Technologies
NSSC
$1.32B
$2.45M 0.36%
82,414
+1,085
+1% +$27.9K
VEA icon
89
Vanguard FTSE Developed Markets ETF
VEA
$229B
$2.36M 0.35%
41,436
+81
+0.2% +$4.34K
TRV icon
90
Travelers Companies
TRV
$78.1B
$2.34M 0.34%
8,751
+90
+1% +$23.7K
XEL icon
91
Xcel Energy
XEL
$48.8B
$2.34M 0.34%
34,340
+410
+1% +$28.4K
ENTG icon
92
Entegris
ENTG
$18.1B
$2.33M 0.34%
28,895
+154
+0.5% +$11.7K
V icon
93
Visa
V
$684B
$2.33M 0.34%
6,550
+1,015
+18% +$354K
UTHR icon
94
United Therapeutics
UTHR
$25.8B
$2.32M 0.34%
8,082
+296
+4% +$88.5K
LNTH icon
95
Lantheus
LNTH
$6.49B
$2.29M 0.34%
27,995
+213
+0.8% +$18.7K
CSX icon
96
CSX Corp
CSX
$93.4B
$2.26M 0.33%
69,175
-3,577
-5% -$108K
SYF icon
97
Synchrony
SYF
$24.7B
$2.24M 0.33%
33,567
-1,267
-4% -$70.8K
COP icon
98
ConocoPhillips
COP
$147B
$2.24M 0.33%
24,938
+184
+0.7% +$16.6K
LOW icon
99
Lowe's Companies
LOW
$117B
$2.15M 0.32%
9,699
+84
+0.9% +$18.7K
SUI icon
100
Sun Communities
SUI
$15.2B
$2.13M 0.31%
16,844
+507
+3% +$62.9K

Similar funds

First National Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
  • First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
  • First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
  • First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
  • First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
  • First National Advisers opened 14 new positions and closed 5 in Q2 2025.
  • First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.

Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.